Curevac partners with Bayer Pharma to boost mRNA Covid vaccine
After BioNTech SE and Pfizer, Moderna and NIH, 3rd mRNA Covid vaccine player CureVac now partners with fellow German company Bayer...
Curevac partners with Bayer Pharma to boost mRNA Covid vaccine
Happy New Year from BlueJet Consulting to our friends, partners, colleagues and clients
Oxford/AstraZeneca Covid-19 vaccine: a vital opportunity for emerging markets
COVID-19 to reshape R&D investments toward infectious diseases
mRNA-based vaccines: a story of immigration, science and resilience
Covid-19 vaccine approval to massively accelerate mRNA innovation
Prepare post-Covid GoToMarket through adapted mix of remote and customer facing activities
The end of Swedish Covid-19 exception ?
Moderna Covid-19 vaccine: 94% efficacy with easier storage
How will Covid-19 vaccines impact economic recovery ?
Complex logistics ahead for Pfizer and BioNTech vaccine
Covid-19 procedure backlog increases patients willingness to pay for surgery
mRNA-based treatments turn body cells into drug factories
V-shaped recovery for procedure volume: impact for Medtech
Boosting Pharma and MedTech productivity with omni-channel go-to-market
BlueJet Consulting Managing Director to speak during Global Commercial Effectiveness Summit
MedTetch Commercial Leaders Forum kick-off
Digital health is going mainstream
Accelerate transition to omnichannel go-to-market
Remote monitoring for cancer patients with Covid-19: lessons learned